Development and psychometric validation of the medical dismissal scale

NCT ID NCT07809373

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 ยท Last updated Sep 09, 2026

Summary

Some people living with long-term physical health conditions report feeling dismissed, disbelieved, or not taken seriously when they seek healthcare. Their symptoms may be downplayed, attributed to psychological causes without good reason, or deprioritised. These experiences are sometimes described as medical dismissal, medical gaslighting or medical invalidation. There is growing concern that these experiences are common and may affect people's willingness to seek care, their trust in healthcare professionals, and their physical and mental health over time. At present, there is no reliable questionnaire designed specifically to measure these experiences in UK healthcare. Without one, it is difficult to know how common medical dismissal is, who is most affected, or whether efforts to improve patient care are working. The aim of this study is to test a new questionnaire, the Medical Dismissal Questionnaire (MDQ). The MDQ has been developed from interviews with people who have used UK healthcare services and describes the range of ways in which patients can feel dismissed by the healthcare system. This study will examine whether the MDQ is a reliable and valid measure, and will look at how experiences of medical dismissal relate to people's health, wellbeing, and use of healthcare over six months. Approximately 1400 adults living in the UK who have used healthcare services at least five times in the past two years will be recruited. Participation is entirely online. People who are interested will be directed to a secure survey where they can read about the study, check their eligibility, and provide consent. Those who take part will be asked to complete four questionnaires over six months: At the start, participants will complete a baseline questionnaire (about 30 to 40 minutes). This asks about background information, long-term conditions, the new MDQ, and other questionnaires about trust in doctors, feeling invalidated, stigma, personality, social desirability, and health literacy. It also includes measures of mood, quality of life, pain, fatigue, and beliefs about health. One week later, participants will complete a shorter questionnaire (about 5 to 10 minutes) that repeats the MDQ and one other measure. This is to check whether MDQ scores are stable over a short period. Three months and six months after the start, participants will complete follow-up questionnaires including the MDQ and measures of mental and physical health. Findings from this study will be used to check whether the MDQ measures what it is intended to measure and whether scores relate to health outcomes over time. In the longer term, the MDQ may be used in research and in healthcare settings to better understand patient experiences and to evaluate efforts to improve patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,641 people

The number who actually took part.

Started

May 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults (18+) in the UK

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (18+) * Able to provide informed consent. * Proficient in English to answer questions about your health * Are a UK resident * Have an email address and phone number * Have used or tried to use healthcare services at least 5 times in the past two years for any kind of health issue. * Have a diagnosis of a long-term condition (e.g., asthma, diabetes, heart disease, IBS, depression) or have experienced a persistent symptom for a period of 6 months Exclusion Criteria: * Lacking capacity to give informed consent. * Under 18 * Not based in the UK * Have not used or tried to use healthcare services at least 5 times in the past two years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Any condition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute of Psychiatry, Psychology and Neuroscience

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.